Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: J Virol Methods. 2014 Mar 26;203:73–80. doi: 10.1016/j.jviromet.2014.03.008

Table 4.

Comparison of p-distance diversities of 454 and SGS data.a,b

454 samples PID 454 APD without correction 454 APD corrected from double mutations APD from MID2 (control) 454 APD corrected from control SGS APD
MID22 1 0.0100 0.0082 0.0016 0.0066 0.0043
MID23 2 0.0184 0.0167 0.0016 0.0151 0.0107
MID24 3 0.0098 0.0097 0.0016 0.0081 0.0057
MID25 4 0.0248 0.0225 0.0016 0.0209 0.0183
MID26 5 0.0127 0.0125 0.0016 0.0109 0.0111
MID28 6 0.0061 0.0038 0.0016 0.0022 0.0014
MID29 7 0.0160 0.0150 0.0016 0.0134 0.0094
MID30 8 0.0085 0.0068 0.0016 0.0052 0.0038
MID31 9 0.0179 0.0165 0.0016 0.0149 0.0120
a

Patient 454 sequences and MID2 control sequences were aligned with HIV-1 subtype B consensus sequence.

b

Welch’s T test, two-tailed between 454 APD without correction and SGS APD, p = 0.064; between 454 APD corrected for background and SGS APD, p = 0.400.